http://2018blcic.boshicloud.com
Co-Sponsors: Peking University Health Science Center & NIH/NCI
Organizer: Peking University 302 Hospital
Co-Organizers:
Western Returned Scholars Association/Medical Doctors Association Youth Committee/NIH Chinese Scholarship Association Asia-Pacific Alliance of Liver Diseases (APALD)
Asia-Pacific Alliance of Liver Diseases Association
Tsinghua University / Center for Synthetic and Systems Biology (CSSB)
Beijing Medical Association/Liver disease Branch
About Conference
Dear Colleagues,
The 2018 Beijing Liver Cancer International Conference (BLCIC) will be held from 2 to 4 Novemver 2018, Beijing, China. This forum will cover issues on surgical treatment, medical treatment, minimally invasive or radiotherapy and interventional therapy, specific nursing and translational medicine research of Hepatobiliary Malignancies. We are delighted to invite you to submit or recommend original research papers to this conference through our Paper Submission System.
Topics
1) Surgical treatment of Hepatobiliary Malignancies
2）Liver Cancer Prevention and Early Screening
3) Immunotherapy and Targeted therapy for
4) Minimally Invasive, Interventional Therapy and Radiotherapy of Liver Cancer
5) Translational Researches of Liver Cancer
6) Specific Nursing of Liver Cancer
Honorary Chairmen
1，Qimin Zhan：
Academician, Peking University
2，Edward L. Trimble：
Founding Director, Center for Global Health (CGH), NCI, NIH
Presiding Chairmen
1，ZHANG Ning：
Vice President, Peking University Health Science Center
2，LU Yinying：
Vice Chairman, Molecular Diagnostic Committee
Speakers
1，WANG Hongyang：
Academician, Chinese Academy of EngineeringDirector
2，DONG Jiahong：
Academician, Beijing Tsinghua Changgung Hospital
3，QIN Shukui：
Deputy Dean, 81 hospital of PLA /Board, CSCO
4，ZHAO Jingmin：
Chairman, Molecular Diagnostic Committee, Chinese Research Hospital Association
Director
5，WANG Xinwei：
Deputy Chief Laboratory of Human Carcinogenesis, NCI, NIH
6，Ghassan Abou-Alfa：
Chief Expert, Memorial Sloan Kettering Cancer Center, America
7，Makuuchi Masatoshi：
Dean, Japan Red Cross Society Medical Center/ Board, IASGO
8，Bin Gao：
Tenured Senior Investigator, Laboratory of Liver Diseases, NIAAA, NIH
9，Ruyi He：
Chief Scientist, National Drug Review Center, CFDA
10，Leonard M. Neckers：
Senior Investigator, NCI, NIH
A total of 41 reporters attended the meeting.
Key Dates
Conference Date:
November 2～4 , 2018
Abstract Submission Deadline:
September 10, 2018
Online Registration Deadline:
October 31, 2018
On-site Registration Date:
November 2～4, 2018
Contact us
Welcome to submit summaries, the summaries can be downloaded from Canada and Medicine(IF = 5). We will invite the authors of the excellent summaries to speak at the conference.
目前是8月底截稿，欢迎各位继续网上投稿，提交摘要。